Australia: A new frontier for therapeutic goods advertising: consultation paper released

Last Updated: 29 September 2017
Article by Dean Gerakiteys

The proposed changes to the Therapeutic Goods Advertising Code are intended to promote four objectives.

As part of its continuing raft of reforms to the Australian therapeutic goods regulatory framework, the Therapeutic Goods Administration (TGA) has released a further consultation paper, seeking stakeholders' views on proposed changes to the Therapeutic Goods Advertising Code 2015 by 13 October 2017.

The last major update to the Code occurred in 2007, and since then there has been a significant expansion of the types of therapeutic goods being promoted and sold to the public, as well as in the methods and media used. Aside from ensuring the Code responds to such a highly dynamic environment, changes are required to:

  • improve the clarity of provisions in light of the proposed changes to the therapeutic goods advertising sanctions and penalties regime; and
  • ensure that the Code is consistent with related reforms to the therapeutic goods regime that may have an impact on advertising, including the introduction of a permitted indications list and a new "assessed listed medicine pathway".

Core objectives

The TGA has recognised that the enhanced enforcement and sanctions regime being introduced will only be effective if the provisions in the Code (to which the legislative reforms are linked) are clear. To this end, the TGA proposes that changes to the Code be made to remove, or at the least, minimise subjectivity, in the interpretation and implementation of specific advertising provisions of the Code.

Aside from pursuing increased clarity, the TGA has also indicated that a new Code will require advertisements to satisfy four core objectives:

Advertisements comply with the Therapeutics Goods Act 1989, Therapeutic Goods Regulations 1990 and the Code.

Advertisements are truthful, balanced and not misleading. Claims about therapeutic goods must be consistent with the entry of the goods in the ARTG. At a high level, that is, an advertisement:

  • must not mislead or deceive, or be likely to mislead or deceive;
  • must not lead a person to believe that are suffering from a serious ailment or that harmful consequence may result from the failure to use a therapeutic good;
  • must not contain any claim, statement or carry any implication that the good is safe or will not cause harm, has no side effects or risks, is effective in all cases or conditions, is guaranteed or a sure cure, or effective for specific demographics (without detailing the supporting evidence);
  • must contain all mandatory and applicable information specified in the Code; and
  • include any specific warning information specified in the Code.

All claims used in advertisements for therapeutic goods must be substantiated. This includes:

  • ensuring that details of scientific information relied upon is publicly accessible;
  • identifying the sponsor of the scientific study(ies) relied upon;
  • detailing any direct or indirect commercial interest held by the sponsor in the therapeutic good or ingredient being promoted; and
  • ensuring that testimonials are not from persons who are employees of or related to the sponsor or advertiser, are genuine and make clear whether any valuable consideration was received.

Advertisements of therapeutics goods must give adequate and appropriate information on any risks, cautions and side effects as well as providing a balance between promoting responsible self-treatment and encouraging consumers to seek timely professional help. This includes:

  • not encouraging, or being likely to encourage inappropriate or excessive use of the goods;
  • not discouraging consumers from taking medicines prescribed by a healthcare professional; and
  • ensuring that sponsorship advertisements promoting a team, individual, competition, event or activity are the subject of the advertising requirements.

It is proposed that these requirements, among others, will be specified in a draft of the Code that will be made available for consultation in the coming months. The TGA is however currently seeking stakeholders' views on the requirements described above and any other details or requirements that they believe should be specified in the new Code.

New definitions of prohibited and restricted representation

The consultation paper also puts forward the proposal that the prohibited claims in the Code being "treatment, cure and prevention" be broadened to include all references to prohibited claims unless otherwise allowed in the Code.

It is also proposed that the list of restricted representations be expanded. For example, it is proposed that the provisions in the Code dealing with "scientific information" be amended to ensure that:

  • references to a specific research study in an advertisement must sufficiently identify the study to allow consumers access to it;
  • advertisements are phrased in educationally appropriate language; and
  • advertisements identify the source or commissioning body for any study relied upon, as well as any relationship to the sponsor or advertiser.

An option for an advertising framework for pharmacist only medicines

The TGA has also proposed a framework for the advertising of pharmacist-only medicines containing Schedule 3 substances. The TGA proposes retaining Appendix H of the Poisons Standard to specify those substances that may be advertised to the public. It would then remain an offence to advertise any Schedule 3 medicine that is not included in Appendix H, directly to consumers.

Next steps


Clayton Utz communications are intended to provide commentary and general information. They should not be relied upon as legal advice. Formal legal advice should be sought in particular transactions or on matters of interest arising from this bulletin. Persons listed may not be admitted in all states and territories.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions